LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Disease Genes Effect May Be Overcome by Other Gene Mutations

By Michal Siman-Tov
Posted on 15 Nov 2016
Print article
A first-of-its-kind study, performed in the model yeast Saccharomyces cerevisiae, shows how “bad genes aren’t always bad news” in that the disease-causing effects of mutations in certain genes can be overcome by suppression-mutations in certain other genes. The study opens a new way for better understanding how some people naturally stay healthy despite having disease-causing mutations, and potentially a new path to better diagnostics and therapies of genetic disorders.

Though little has been known about the mechanisms of genetic suppression, researchers are uncovering the general rules behind it. An international team of researchers led by Professors Brenda Andrews, Charles Boone, and Frederick Roth of the University of Toronto School of Medicine (Toronto, Ontario, Canada) and Professor Chad Myers of the University of Minnesota-Twin Cities (Minneapolis, MN, USA) have compiled the first comprehensive set of suppressive mutations in a cell. Their findings could help explain how suppressive mutations combine with disease-causing mutations to reduce or even prevent a genetic disorder.

This curious bit of biology has come to light as increasing numbers of healthy people have had their genomes sequenced. Among them are a few who remain healthy despite carrying catastrophic mutations that usually cause debilitating disorders, such as Cystic Fibrosis or Fanconi anemia.

“We don’t really understand why some people with damaging mutations get the disease and some don’t. Some of this could be due to environment, but a lot of could be due to the presence of other mutations that are suppressing the effects of the first mutation,” said Prof. Roth. Certain suppression mutations can keep cells healthy despite otherwise damaging mutations. “If we know the genes in which these suppressive mutations occur, then we can understand how they relate to the disease-causing genes and that may guide future drug development,” said first author Dr. Jolanda van Leeuwen.

“A study like this has never been done on a global scale. And since it is not possible to do these experiments in humans, we used yeast as a model organism, in which we can know exactly how mutations affect the cell’s health,” said Dr. Van Leeuwen.

The researchers took a two-pronged approach. On the one hand, they analyzed all published data on known suppressive relationships between yeast genes. While informative, these results were inevitably skewed towards the most popular genes – the ones scientists have already studied in detail. So they also carried out an unbiased analysis by experimentally measuring how well the cells grew when they carried a damaging mutation on its own, or in combination with another mutation.

Because harmful mutations slow down cell growth, any improvement in growth rate was due to the suppressive mutation in a second gene. These experiments revealed hundreds of suppressor mutations for the known damaging mutations. Importantly, regardless of the approach, the data point to the same conclusion: to find suppressor genes, there is often no need to look far from the genes with damaging mutations. The genes tend to have related roles in the cell – mainly either that their protein products are physically located in the same place, or that they work in the same molecular pathway.

“We’ve uncovered fundamental principles of genetic suppression and show that damaging mutations and their suppressors are generally found in genes that are functionally related. Instead of looking for a needle in the haystack, we can now narrow down our focus when searching for suppressors of genetic disorders in humans,” said Prof. Boone.

The study, by van Leeuwen J, Pons C, et al, was published November 4, 2016, in the journal Science.

Related Links:
University of Toronto School of Medicine
University of Minnesota-Twin Cities
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more